Target Name: ZNF512B
NCBI ID: G57473
Review Report on ZNF512B Target / Biomarker Content of Review Report on ZNF512B Target / Biomarker
ZNF512B
Other Name(s): zinc finger protein 512B | OTTHUMP00000031611 | KIAA1196 | GM632 | Zinc finger protein 512B | Z512B_HUMAN | MGC149846 | MGC149845

ZNF512B: A Potential Drug Target and Biomarker

Zinc finger proteins (ZFPs) are a family of transmembrane proteins that play a crucial role in various cellular processes. One of the ZFPs, ZNF512B, has been identified as a potential drug target and biomarker. In this article, we will discuss the ZNF512B protein, its functions, potential drug targets, and potential applications as a biomarker.

ZNF512B: Structure and Function

ZNF512B is a 21 kDa protein that contains a zinc finger domain and a non-Zinc Finger domain (NZFD). The zinc finger domain is a conserved structural feature that is characterized by a central lysine residue, a positively charged amino acid residue, and a variable number of additional amino acids. The NZFD is a unique feature that is found in some ZFPs and is responsible for the protein's stability and interactions with other proteins.

ZNF512B is a nuclear protein that is expressed in various tissues, including brain, heart, and muscle. It is highly expressed in the brain and has been shown to be involved in various cellular processes, including cell growth, differentiation, and inflammation. ZNF512B has also been shown to play a role in the development and progression of various diseases, including cancer.

Potential Drug Target

ZNF512B is a potential drug target due to its unique structure and various functions. One of its potential drug targets is the regulation of cell growth and differentiation. ZNF512B has been shown to play a role in the regulation of neuronal stem cell (NSC) proliferation and differentiation. It has been shown to inhibit the activity of the transcription factor, SMAD, which is involved in the regulation of NSC proliferation.

In addition to its role in cell growth and differentiation, ZNF512B has also been shown to play a role in the regulation of inflammation. It has been shown to regulate the production of pro-inflammatory cytokines, such as TNF-伪, by suppressing the activity of the transcription factor, NF-kappa-B.

Potential Biomarker

ZNF512B has also been shown to be a potential biomarker for various diseases. For example, it has been shown to be involved in the development and progression of cancer, including neurobladder cancer. ZNF512B has also been shown to be involved in the development of cardiovascular disease, including myocardial infarction.

In addition to its potential as a drug target, ZNF512B has also been shown to be a potential biomarker for various diseases. It has been shown to be involved in the development and progression of cancer, including neurobladder cancer, and has been shown to be involved in the development of cardiovascular disease, including myocardial infarction.

Conclusion

ZNF512B is a unique and conserved protein that has been shown to play a role in various cellular processes. Its potential drug target and biomarker status make it an attractive target for further research and development. Further studies are needed to fully understand the functions of ZNF512B and its potential as a drug and biomarker.

Protein Name: Zinc Finger Protein 512B

Functions: May be involved in transcriptional regulation

The "ZNF512B Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZNF512B comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

ZNF513 | ZNF514 | ZNF516 | ZNF516-DT | ZNF517 | ZNF518A | ZNF518B | ZNF519 | ZNF519P3 | ZNF521 | ZNF524 | ZNF525 | ZNF526 | ZNF527 | ZNF528 | ZNF528-AS1 | ZNF529 | ZNF529-AS1 | ZNF530 | ZNF532 | ZNF534 | ZNF536 | ZNF540 | ZNF541 | ZNF542P | ZNF543 | ZNF544 | ZNF546 | ZNF547 | ZNF548 | ZNF549 | ZNF550 | ZNF551 | ZNF552 | ZNF554 | ZNF555 | ZNF556 | ZNF557 | ZNF558 | ZNF559 | ZNF559-ZNF177 | ZNF560 | ZNF561 | ZNF561-AS1 | ZNF562 | ZNF563 | ZNF564 | ZNF565 | ZNF566 | ZNF566-AS1 | ZNF567 | ZNF568 | ZNF569 | ZNF56P | ZNF57 | ZNF570 | ZNF571 | ZNF571-AS1 | ZNF572 | ZNF573 | ZNF574 | ZNF575 | ZNF576 | ZNF577 | ZNF578 | ZNF579 | ZNF580 | ZNF582 | ZNF582-DT | ZNF583 | ZNF584 | ZNF585A | ZNF585B | ZNF586 | ZNF587 | ZNF587B | ZNF589 | ZNF592 | ZNF593 | ZNF594 | ZNF594-DT | ZNF595 | ZNF596 | ZNF597 | ZNF598 | ZNF599 | ZNF600 | ZNF603P | ZNF605 | ZNF606 | ZNF607 | ZNF608 | ZNF609 | ZNF610 | ZNF611 | ZNF613 | ZNF614 | ZNF615 | ZNF616 | ZNF618